Constellation Energy has agreed to pay $715 million in cash for the Rhode Island State Energy Center, the state’s largest electricity generator by output, in a deal that hands Shell a clean exit from a 609-megawatt combined-cycle plant it has owned since 2002. The transaction is subject to regulatory approval and customary purchase-price adjustments, with both sides targeting a first-quarter 2027 close.
The price and the adjustments
Constellation frames the effective outlay at $580 million after $135 million of expected first-year tax benefits, a figure the buyer highlighted in its own release. The source does not disclose a break fee, a go-shop period, or any premium to an undisturbed trading price, standard omissions for a private-asset sale but notable in a market where sellers increasingly extract process protections. Shell did not comment on whether the proceeds are earmarked for debt reduction, buybacks, or reinvestment.
What Constellation gets
RISEC runs two combustion turbines and a steam turbine in combined-cycle mode, capturing waste heat to lift efficiency above single-cycle peers. Constellation chief executive Joe Dominguez said the asset “checks all of these boxes” for grid position and gas-pipeline access as the company expands in New England. The buyer claims immediate accretion to operating profit and insists the purchase will not derail a $5 billion share-repurchase target set for the end of 2027.
Shell’s simultaneous buy
While selling RISEC, Shell Energy North America acquired Hunlock Creek Generation, a pair of Pennsylvania gas plants totaling 169 megawatts, for an undisclosed sum. One unit is a 44-megawatt peaker that earns capacity-market revenue in PJM Interconnection, the largest U.S. wholesale power market, on top of energy payments during scarcity events. Shell says the deal secures supply and capacity offtake for its Mid-Atlantic book and expects returns to exceed its internal hurdle rate for power investments.
What to watch
Regulatory clearance in multiple jurisdictions is the only stated condition to close. The nine-month timeline suggests neither party anticipates a protracted review, but the source offers no detail on required approvals. Constellation’s accretion claim and share-repurchase pledge will be tested once RISEC’s actual dispatch economics and tax-benefit realization are visible in 2027 results. Shell’s Hunlock IRR target, meanwhile, remains unquantified.